Status:
UNKNOWN
Research of Optimal Cerebral Perfusion Pressure Diagnosis
Lead Sponsor:
Vilnius University
Collaborating Sponsors:
Kaunas University of Technology
Conditions:
Trauma, Brain
Hemorrhage Cerebral
Eligibility:
All Genders
18+ years
Brief Summary
The research will investigate the hypothesis that timely identification of the optimal value of the cerebral perfusion pressure (optCPP) or optimal arterial blood pressure (optABP) is possible after d...
Detailed Description
Optimal cerebral perfusion pressure (optCPP) management requires at least 4 hours of patients' physiological data monitoring. Critical pathophysiological events in the injured brain happen in minutes,...
Eligibility Criteria
Inclusion
- Traumatic brain injury patients
- Subarachnoid hemorrhage patients
Exclusion
- persons with mental disorders, but who can give consent to participate in biomedical research;
- minors;
- students, if their participation in biomedical research is related to studies;
- persons living in care institutions;
- soldiers during their actual military service;
- employees of health care institutions where biomedical research is conducted, subordinate to the researcher;
Key Trial Info
Start Date :
June 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06028906
Start Date
June 21 2021
End Date
December 1 2024
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vilnius University Hospital Santaros klinikos
Vilnius, Lithuania, 08661